Avalyn Pharma Inc.

États‑Unis d’Amérique

 
Quantité totale PI 28
Rang # Quantité totale PI 51 424
Note d'activité PI 2,2/5.0    24
Rang # Activité PI 33 329

Brevets

Marques

18 0
7 0
3 0
0
 
Dernier brevet 2023 - Nintedanib and nintedanib combin...
Premier brevet 2012 - Aerosol pirfenidone and pyridone...

Derniers inventions, produits et services

2023 Invention Nintedanib and nintedanib combination dry powder compositions and uses. The invention includes dr...
Invention Aerosol pirfenidone and pyridone analog compounds and uses thereof. Disclosed herein are formula...
2021 Invention Aerosol tyrosine kinase inhibitor compounds and uses thereof. Disclosed herein are formulations ...
Invention Nebulizer device optimization for improved aerosol parameters and uses thereof. Disclosed herein...
Invention Nebulizer device optimization for improved aerosol parameters and uses thereof. Disclosed herein ...
Invention Specially formulated compositions of inhaled nintedanib and nintedanib salts. Disclosed herein ar...
Invention Aerosol pirfenidone and pyridone analog compounds and uses thereof. Disclosed herein are formulat...
2020 Invention Inhaled imatinib for treatment of pulmonary arterial hypertension (pah). Disclosed herein are for...
Invention Inhaled imatinib for treatment of pulmonary arterial hypertension (pah). Disclosed herein are fo...
Invention Aerosol pirfenidone and pyridone analog compound and uses thereof. Disclosed herein are formulati...
2014 Invention Aerosol imatininb compounds and uses thereof. Disclosed herein are formulations of imatinib or a ...
Invention Aerosol nintedanib compounds and uses thereof. Disclosed herein are formulations of nintedanib or...
2012 Invention Aerosol pirfenidone and pyridone analog compounds and uses thereof. Formulations of pirfenidone o...